RT Journal Article
SR Electronic
T1 Pattern of COVID-19 Epidemics in Japan Influenced by Control Measures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.24.21253923
DO 10.1101/2021.03.24.21253923
A1 Konishi, Tomokazu
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.24.21253923.abstract
AB Background COVID-19 has spread worldwide since it appeared in 2019. In contrast to many other countries with epidemics, Japan differed in that it avoided lockdowns and instead asked people for self-restraint. A travel campaign was conducted with a huge budget, but the number of PCR tests is severely limited. These choices may have influenced the course of the epidemic.Methods The increase or decrease in the classes of SARS-CoV-2 variants was estimated by analyzing the published sequences with an objective multivariate analysis. This methodology does not rely on unverifiable assumptions. It observes the samples in multiple directions, digesting complex differences into simpler forms. The results were compared over time with the number of confirmed cases, PCR tests, and overseas visitors.Results Three epidemic peaks in Japan have been caused by domestically mutated variants. However, due to the relaxation of immigration restrictions, several infective variants have been imported from abroad and are currently competing for expansion. In other countries, there are few other cases where multiple variants have peaked. The chaotic situation in Japan will continue for a while, in part, because no effort has been made to find asymptomatic carriers and details of the vaccination program are undecided.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Akita Prefectural UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is available in Figshare. https://doi.org/10.6084/m9.figshare.13315628.v1